BMY NVDA Bristol Myers Squibb is buying Nvidia's newest enterprise AI Computing system to use for drug Discovery and development. Bristol My

BMY NVDA Bristol Myers Squibb is buying Nvidia's newest enterprise AI Computing system to use for drug Discovery and development. Bristol Myers said using older Nvidia hardware has already changed its R&D process. Now it's got more horsepower to work with. Club names Eli Lilly and Nvidia also have a partnership for AI drug Discovery. - per Cramer Investing Club Newsletter